---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-032784"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2024-07-10T23:59:59+00:00"
generated_at: "2026-05-31T22:00:45.590732+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sanuwave Health reports preliminary Q2 2024 revenue of $7.0-7.2M, highest quarterly revenue in history

## Summary
- Preliminary Q2 2024 revenue $7.0M-$7.2M; up 50%-54% vs Q2 2023 and highest quarterly revenue ever.
- UltraMist revenue grew >60% YoY and represents ~97% of total company revenue.
- UltraMist applicator sales set all-time quarterly record, accounting for ~65% of total revenue.
- Company expects to release full Q2 results in mid-August 2024; guidance at upper end of prior range.

## SEC filing metadata
- accession: 0001140361-24-032784
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2024-07-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000114036124032784/0001140361-24-032784-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000114036124032784/ef20032251_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-032784
- JSON: https://secwatch.observer/filing/0001140361-24-032784.json
- Plain text: https://secwatch.observer/filing/0001140361-24-032784.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.